`

Inmagene Biopharmaceuticals

Biotechnology Research

Specialities :
Immunology
Inflammation
Biotechnology
Ox40
Btk

+2

revenue-icon Revenue
11M - 100M
funding-icon Total Funding
$100.0M
size-icon Size
11 - 50

Frequently Asked Questions About Inmagene Biopharmaceuticals

What does Inmagene biopharmaceuticals do?+

Inmagene is a global clinical-stage biotechnology company developing novel therapeutics for I&I diseases. The companys highly differentiated clinical-stage pipeline has multiple candidates with best-in-class potential. The lead asset IMG-007, a non-depleting anti-OX40 mAb, is in two global Phase 2a clinical trials in atopic dermatitis and alopecia areata. IMG-004, a non-covalent reversible BTK inhibitor is in a Phase 1 multiple ascending dose (MAD) study. IMG-008, an in-house developed long-acting anti-IL-36R mAb is entering global Phase 1 clinical development

What are Inmagene biopharmaceuticals's specialties? +

Immunology ,inflammation,biotechnology,ox40,btk,il-36r,and i&i

What is Inmagene biopharmaceuticals's industry? +

Inmagene biopharmaceuticals operates in the Biotechnology research industry.

What is Inmagene biopharmaceuticals's revenue? +

Inmagene biopharmaceuticals's revenue is 11m - 100m

What is Inmagene biopharmaceuticals's company size? +

Inmagene biopharmaceuticals has 11 - 50 employees.

The Go-to Sales Technology According to G2

G2 Badges Map
Get Started With Clodura
Sign Up

Sign Up for Free

Get Started with the Free Forever plan! No credit card needed. Enjoy up to 10,000 free email credits per month at no cost.

Supercharge Your Prospecting

Supercharge Your Prospecting

Start Prospecting from Clodura.AI's database of 600M+ verified B2B contacts and 120M+ direct dials along with 18M+ companies' org charts.

Grow Your Business

Grow Your Business

Unlock the prospect's contact details, including verified email, direct dials, add them to cadence, and close more deals.